Evidence map›Paper›PMID 38254770›Full record

ArticleCancers2024

Coefficient of Variation in Metastatic Lymph Nodes Determined by

Sara Pellegrino, Rosa Fonti, Carlo Vallone, Rocco Morra, Elide Matano, Sabino De Placido, Silvana Del Vecchio

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Advances in lymphatic metastasis of non-small cell lung cancer.Cell communication and signaling : CCS · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sara PellegrinoDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Rosa FontiDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Carlo ValloneDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Rocco MorraDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-2516-076X
Elide MatanoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
Sabino De PlacidoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
Silvana Del VecchioDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0002-5466-1213
University of Naples Federico II · IT

Funding

Italian Association for Cancer Research IG 2021 - ID. 25945 project - P.I. Silvana Del VecchioMinistry of Education, Universities and Research MUR PRIN 2022 Project N. 2022F5N25M
6 · The paper itself

Abstract

Purpose The aim of the present study was to test whether the coefficient of variation (CoV) of

Indexed as

18F-FDG PET/CTcoefficient of variationheterogeneity of glycolytic phenotypenon-small cell lung cancerprognosis

Identifiers

PMID38254770
PMCPMC10813913
OpenAlexW4390780481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.